Using higher doses to compensate for tubing residuals in extended-infusion piperacillin-tazobactam

Wendy J Lam1, Tanaya Bhowmick, Alan Gross

  • 1Rutgers University Ernest Mario School of Pharmacy, Piscataway, NJ, USA. Wendy.Jung@gmail.com

Abstract

Insights

Drug losses from intravenous pump tubing residuals can be compensated by increasing infusion volumes or using higher doses of piperacillin-tazobactam (PT). Adjusting PT dosing ensures effective treatment despite residual medication in infusion lines.

Area of Science:

  • Pharmacology
  • Pharmaceutical Technology
  • Clinical Pharmacy

Background:

  • Intravenous (IV) infusion lines retain residual drug volumes after administration.
  • This residual volume can lead to sub-therapeutic dosing, particularly with extended-infusion regimens.
  • Optimizing drug delivery is crucial for maximizing therapeutic efficacy.

Purpose of the Study:

  • To mathematically assess drug losses in IV infusion lines.
  • To evaluate methods for compensating drug loss due to residual volumes in IV pump tubing.
  • To inform dosing strategies for extended-infusion piperacillin-tazobactam.

Main Methods:

  • A literature review was conducted using Ovid MEDLINE and reference citations.
  • Search terms included tubing residuals, residual volume, piperacillin-tazobactam, and infusion pumps.
  • Studies focusing on extended-infusion piperacillin-tazobactam implementation were included.

Main Results:

  • Two studies addressed tubing residuals, both recommending increased infusion volumes.
  • One study suggested reducing infusion line dead space with alternative pump systems.
  • Calculations indicated higher piperacillin-tazobactam doses can compensate for tubing residuals.

Conclusions:

  • Extended-infusion piperacillin-tazobactam aims to maximize pharmacodynamic target attainment.
  • Higher piperacillin-tazobactam doses are a viable strategy to offset drug loss in IV pump tubing.
  • This approach ensures adequate drug delivery despite residual volumes.

Related Concept Videos

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
IV Infusion to Oral Dosing: Conversion Methods01:28

IV Infusion to Oral Dosing: Conversion Methods

The development of extended-release formulations has facilitated the transition from intravenous to oral medication, offering a more convenient and patient-friendly approach to drug administration. This transition, however, requires careful management to ensure that therapeutic drug levels are maintained, preserving efficacy and avoiding adverse effects. Understanding pharmacokinetic principles and dosage calculations is critical during this process.Pharmacokinetics of the...
Drug Accumulation During Multiple Dosing: Repetitive IV Injections01:21

Drug Accumulation During Multiple Dosing: Repetitive IV Injections

Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
Dosage Interval and Administration Route: Determination Methods01:19

Dosage Interval and Administration Route: Determination Methods

A medication’s effectiveness largely depends on its appropriate dosage and the route of administration. Dosage ensures that a sufficient drug concentration is maintained in the bloodstream to elicit the desired therapeutic effect without causing toxicity. The route of administration affects the drug's bioavailability, rate of absorption, and onset of action, which are crucial for achieving optimal therapeutic outcomes. Drug dosage calculations are critical to tailoring therapy to individual...